MedTrace Logo

FUS-TB VS COG-TB in Small Lesions of Prostate Cancer

NCT06504017 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-07-16

No results posted yet for this study

Summary

To compare the positive detection rates of COG-TB vs FUS-TB for prostate cancer with PI-RADS 4 small lesions.

Conditions

Interventions

PROCEDURE

COG-TB: Cognitive Fusion guided prostate targeted Biopsy

Cognitive Fusion guided targeted Biopsy 4 cores under cognitive fusion ultrasound

PROCEDURE

FUS-TB: MRI-TRUS Fusion guided prostate targeted Biopsy

MRI-TRUS Fusion guided targeted Biopsy 4 cores under cognitive fusion ultrasound

Sponsors & Collaborators

  • Huai'an First People's Hospital

    collaborator OTHER

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Shangqian Wang, PhD · The First Affiliated Hospital with Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-31
Primary Completion
2025-05-31
Completion
2025-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06504017 on ClinicalTrials.gov